相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway
K. T. Doepfner et al.
LEUKEMIA (2007)
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
Francois Guilhot et al.
BLOOD (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines
E. Pastural et al.
ONCOGENE (2007)
Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation
Addolorata Maria Luce Coluccia et al.
EMBO JOURNAL (2007)
Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression
Stuart A. Scott et al.
EXPERIMENTAL HEMATOLOGY (2007)
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts
P. L. Tazzari et al.
LEUKEMIA (2007)
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Deepali Sachdev et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells
Sangkil Nam et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Growth factor receptor interplay and resistance in cancer
Helen E. Jones et al.
ENDOCRINE-RELATED CANCER (2006)
Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice
Yiguo Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation
Andrea Hoelbl et al.
BLOOD (2006)
Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML)
M Scherr et al.
BLOOD (2006)
Cross-talk between IGF-I and TGF-β signaling pathways
D Danielpour et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and β-catenin
J Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression
Y Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia
YG Hu et al.
NATURE GENETICS (2004)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Insulin-like growth factors and neoplasia
MN Pollak et al.
NATURE REVIEWS CANCER (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Mechanisms of growth hormone (GH) action - Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation
J Woelfle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Growth hormone insensitivity associated with a STAT5b mutation
EM Kofoed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis
MB Wilson et al.
ONCOGENE (2002)
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
M Mayerhofer et al.
BLOOD (2002)
The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells
A Klejman et al.
EMBO JOURNAL (2002)
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia
DJ Barnes et al.
ACTA HAEMATOLOGICA (2002)
IGF-I receptor signalling in transformation and differentiation
B Valentinis et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Numerous growth factors, cytokines, and chemokines are secreted by human CD34+ cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner
M Majka et al.
BLOOD (2001)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of β-catenin
MP Playford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck
JM Lionberger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The role of STAT proteins in growth hormone signaling
J Herrington et al.
ONCOGENE (2000)
分享论文
